Back
ESC2025 Premium Access

Newer GLP-1 receptor agonists and clinical outcomes in heart failure with reduced ejection fraction: a real-world comparative study

Session: Comorbidities and heart failure therapies
Topic: Pharmacotherapy
Speaker: Associate Professor A. Kalogeropoulos (Stony Brook, US)
Event: ESC Congress 2025

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Andreas Kalogeropoulos

Stony Brook University, Stony Brook (United States of America)
1 presentation
0 follower

5 more presentations in this session

Frailty status, aging, and mortality risk in heart failure

Speaker: Miss C. Garred (Herlev, DK)

Access
Abstract
Slides
Video
Like
Thumbnail

The impact of malnutrition severity on mortality risk in super-elderly patients with acute heart failure: a Geriatric Nutritional Risk Index-based assessment

Speaker: Doctor T. Murakami (Maebashi, JP)

Access
Abstract
Slides
Video
Like
Thumbnail

Incidence and outcomes of dementia after a diagnosis of heart failure: a population-based study

Speaker: Mr P. Tieu (Toronto, CA)

Access
Abstract
Slides
Video
Like
Thumbnail

Heart failure treatment optimization in patients with dystrophin-related muscular dystrophy and HFrEF

Speaker: Doctor L. Monzo (Vandoeuvre-Les-Nancy, FR)

Access
Abstract
Slides
Video
Like
Thumbnail

Comorbidity burden in patients with cardiogenic shock: a cardiogenic shock working group analysis

Speaker: Doctor J. Sundermeyer (Hamburg, DE)

Access
Abstract
Slides
Video
Like
Thumbnail

Access the full session

Comorbidities and heart failure therapies

Speakers: Associate Professor A. Kalogeropoulos, Miss C. Garred, Doctor T. Murakami, Mr P. Tieu, Doctor L. Monzo...
Access
Video
Like
Thumbnail

About the event

Image

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources